H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Parents choosing alternative vaccine schedules for their kids: Survey

Parents choosing alternative vaccine schedules for their kids: Survey

DNA primer vaccine enhances immune response to H5N1 avian influenza vaccine

DNA primer vaccine enhances immune response to H5N1 avian influenza vaccine

Dialysis patients with kidney failure more likely to develop serious complications from flu

Dialysis patients with kidney failure more likely to develop serious complications from flu

Two Influenza test kits receive FDA clearance for use in JBAIDS

Two Influenza test kits receive FDA clearance for use in JBAIDS

Microbiologist offers advice to guard against coming down with the flu

Microbiologist offers advice to guard against coming down with the flu

Asthma patients admitted to hospital with H1N1 are half as likely to die from infection

Asthma patients admitted to hospital with H1N1 are half as likely to die from infection

Britain’s health workers urged to get flu shots to protect patients

Britain’s health workers urged to get flu shots to protect patients

People should be concerned about flu every year

People should be concerned about flu every year

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

Something like 'Contagion' could happen for influenza

Something like 'Contagion' could happen for influenza

“Contagion” movie entirely plausible

“Contagion” movie entirely plausible

Walgreens, MDA team up to offer free seasonal flu shots

Walgreens, MDA team up to offer free seasonal flu shots

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission

Three cases of novel influenza A virus now linked to agricultural fair in southwestern Pennsylvania

Three cases of novel influenza A virus now linked to agricultural fair in southwestern Pennsylvania

Scientists hope to create models that can more accurately predict spread of disease

Scientists hope to create models that can more accurately predict spread of disease

Finland national health institute finds link between H1N1 flu vaccine and children's narcolepsy

Finland national health institute finds link between H1N1 flu vaccine and children's narcolepsy

Tamiflu resistant flu found in Newcastle, Australia

Tamiflu resistant flu found in Newcastle, Australia

Study finds children's hospitals underequipped to handle H1N1 pandemics

Study finds children's hospitals underequipped to handle H1N1 pandemics

FDA clears IQuum's Liat influenza A/B assay, analyzer

FDA clears IQuum's Liat influenza A/B assay, analyzer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.